Lilly Asia Ventures is a venture capital firm. The firm makes venture capital investments in the life sciences and healthcare sectors in Asia, with a focus on China. It was founded in 2008 and is based in Shanghai, China.
Lilly Asia Ventures wants to become the partner for entrepreneurs seeking capital and to build great companies developing products that treat diseases and improve human health.
Lilly Asia Ventures originated as a corporate venture subsidiary of Eli Lilly, until they spun off and became an independent investment management company. They manage over $1.2 billion of committed capital.
Timeline
Invested in
Associated Investment Funds
Patents
Funding Rounds Participated In
Further Resources
Title
Author
Link
Type
Date
News
Title
Author
Date
Publisher
Description
Emmy Lucas
September 10, 2021
FierceBiotech
OrbiMed Advisors and Lilly Asia Ventures are two key players pouring money into RNA-targeting technology via ADARx Pharmaceuticals' $75 million series B round. The funding will take the San Diego-based biotech's growing pipeline of RNA-targeting therapeutics into the clinic, ADARx said in a statement on Wednesday.
FinSMEs
May 10, 2021
FinSMEs
About | Advertise | Contact | Disclaimer | News | The Daily Deal Newsletter FinSMEs.com by FinSMEs is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License.
Alebund Pharmaceuticals
May 10, 2021
www.prnewswire.com:443
/PRNewswire/ -- Alebund Pharmaceuticals ("Alebund" or the "Company"), a biopharmaceutical company dedicated to developing innovative therapies for the...
Regor Therapeutics Group
February 19, 2021
www.prnewswire.com:443
/PRNewswire/ -- Regor Therapeutics, a clinical stage biotechnology company dedicated to the discovery of innovative medicines to treat cancer, immune disorders...
November 27, 2020
BioSpace
Eluminex Biosciences, an Ophthalmology-Focused Biotechnology Company, Announces Closing of $50 Million Series A Financing - read this article along with other careers information, tips and advice on BioSpace
SHOW MORE
References
Organization
Investor
Venture capital firm
CompanyCompany attributes
Industry
Biotechnology
Shanghai
Hong Kong
Menlo Park, California
Huangpu District, ShanghaiCompany Operating Status
Active
Pitchbook URL
Spun Out From
Eli Lilly and CompanyFull Address
Room2909-14, 168 Hubin Road, Huangpu District, Shanghai, China.
Unit 902-904, Two ChinaChem Central, 26 Des Voeux Road Central, Hong Kong
2730 Sand Hill Road, Suite 130, Menlo Park, CA
2735 Sand Hill Road, Suite 210 Menlo Park, CA
Room 606-7, St. George's Building, 2 Ice House Street, Central, Hong Kong
Founded Date
2008
Email Address
info@lavfund.com
Phone Number
+862123169588
Categories
Related Topics
Contributors
- 1
Aleksander Holm
Interested in understanding the world we live in. - 2
Melanie Manipula
Helping organize knowledge. - 3
Duzenko Andrey
Extensive experience in development and interaction with the community - 4
Katrina-Kay Pettitt
Data Duchess @ Golden - 5
Neelam Jhaveri
Techno Geek + Gamer + Fashionista + Sense of Humor = It's ME - 6
Aime Anne Nisay
QA Engineer of web and mobile applications - 7
Ирина Носкова
Programmer - 8
Julius John Villarisco
Every day is a new learning for me, new opportunity every time. Never limit my self, think outside the box.